Croma Oncologia
Croma Oncologia is a Brazilian integrated oncology care provider operating four units in São Paulo and Rio de Janeiro, delivering coordinated cancer treatment, diagnostics, infusion, and multidisciplinary support to insured, private-pay, and corporate patients via its Navegação Oncológica 360° model.
- Company typePrivate
- Founded-
- HeadquartersSão Paulo, Brazil
- Headcount51–100
- GTM typeB2B and B2C
- OfferingServices
What Croma Oncologia does
Croma Oncologia (legal entity ABPF ONCOLOGIA S.A.) is a Brazilian integrated oncology care provider operating four coordinated units across São Paulo (Lapa, Tatuapé, Brooklin) and Rio de Janeiro (Botafogo). It was formed as a strategic joint venture among BP – Beneficência Portuguesa de São Paulo (hospital infrastructure), Atlântica Hospitais e Participações / Grupo Bradesco Seguros (payer and hospital operations), Grupo Fleury (diagnostics), Felipe Mattoso, and Labs A+ — a structure that gives Croma vertical reach across hospital, diagnostic, and payer layers of oncology care. Its core product is the "Navegação Oncológica 360°," a coordinated care navigation model that accompanies cancer patients from diagnosis through post-treatment, integrating consultations, chemotherapy, immunotherapy, targeted therapy, radiotherapy, surgery, biopsy, infusion, and multidisciplinary support (psychology, nutrition, physiotherapy, nursing, speech therapy, stomatology, clinical pharmacy). The underlying technology is a shared digital infrastructure linking clinics, laboratories (Fleury/Labs A+), and hospital partners (BP/Atlântica), with a patient portal (odycare.app) for appointments, exam results, and care-team communication, plus WhatsApp- and phone-based intake. Croma bills through a hybrid model: (a) Brazilian convênios with a broad set of national and international payers including Bradesco Saúde, Mediservice, Aetna, Ever, MSH International, and IMG; (b) private/particular out-of-pocket payment with personalized quotes; and (c) value-based, shared-risk managed services contracts with health insurance operators and corporate employers, which bundle predictable costs with clinical/performance reporting. Go-to-market combines institutional channels (operator and corporate sales) with direct-to-consumer acquisition via WhatsApp, a "Sobre o Câncer" educational blog, earned media, and events such as CONARH 2025.
Croma Oncologia firmographics
Firmographics- Name
- Croma Oncologia
- Legal name
- ABPF ONCOLOGIA S.A.
- Website
- https://cromaoncologia.com.br
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Croma Oncologia is a Brazilian integrated oncology care provider operating four units in São Paulo and Rio de Janeiro, delivering coordinated cancer treatment, diagnostics, infusion, and multidisciplinary support to insured, private-pay, and corporate patients via its Navegação Oncológica 360° model.
- Ownership category
- akta.pro rank
Croma Oncologia industry classification
Industry- Product category
- Oncology Care Services
- NAICS
- Offices of Physicians (62111), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Hospitals (8060), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)
- akta.pro secondary industries
- Oncology & Cancer Specialty Hospitals (HLAFAHAC), Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM), Medical Oncology (HLAKAFAB)
Keywords
Where Croma Oncologia is headquartered
LocationHeadquarters
- HQ city
- São Paulo
- HQ country
- Brazil
- HQ region
- Latin America
Offices4 records
Markets served
Croma Oncologia business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Health Insurance (Convênio): Croma Oncologia bills through the Brazilian health insurance system (operadoras de saúde), providing covered oncology services to insured patients. The company accepts a wide range of national and international health insurance providers including Bradesco Saúde, Mediservice, Aetna, and others.
- Private/Particular Payment: Individual patients without health insurance can pay out-of-pocket with customized budgets tailored to their specific needs, covering consultations, procedures, and treatments.
- Value-Based Care Contracts with Operators: Croma offers health insurance operators and corporate clients a value-based, efficient care model with shared risk, predictable costs, and transparent reporting of clinical and performance indicators. This model aligns incentives around efficient, outcomes-driven oncology care.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Health Insurance (Convênio) – covered services billed through Brazilian health insurance operators |
| Other | Pay-as-you-go | Private/Particular – out-of-pocket payment for uninsured patients |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels6 records
Croma Oncologia product offering
Product offeringCore offering
Croma Oncologia operates a coordinated oncology care platform that integrates outpatient clinics, diagnostic services, and hospital facilities under its Navegação Oncológica 360° model. The company provides comprehensive cancer treatment — including consultations, chemotherapy, immunotherapy, targeted therapy, radiotherapy, surgeries, biopsies, hematology/onco-hematology, and multidisciplinary support — delivered across four physical units in São Paulo and Rio de Janeiro. Services are funded through Brazilian health insurance operators, private out-of-pocket payment, and value-based care contracts with operators and corporate clients.
Product overview
Croma Oncologia is a healthcare company offering a unified coordinated care model centered on the Navegação Oncológica 360° (Coordinated Care Navigation 360°), which integrates Plataformas Digitais for patient tracking alongside comprehensive oncology services. The portfolio includes Consultas com Especialistas em Oncologia, Exames Laboratoriais e de Imagem, Biópsias e Procedimentos Diagnósticos, Quimioterapia e Radioterapia, Equipe Multidisciplinar, and Cirurgias Oncológicas. Additional offerings include an Espaço de Bem-Estar for integrative therapies and the Sobre o Câncer educational blog. The company operates four units in São Paulo (Lapa, Tatuapé, Brooklin) and Rio de Janeiro (Botafogo).
Differentiator
Problem solved
Functional benefit
Products and services
- Navegação Oncológica 360° (Coordinated Care Navigation 360°) A coordinated care model that accompanies patients throughout the entire oncology journey, from diagnosis through post-treatment follow-up, coordinating appointments, exams, multidisciplinary support, and processes with the health insurance operator.
- Consultas com Especialistas em Oncologia Personalized appointments with oncology specialists covering clinical oncology, surgical oncology, mastology, and urology for accurate diagnosis and individualized treatment planning.
- Exames Laboratoriais e de Imagem Complete diagnostic laboratory and imaging exams aimed at precision and agility in starting treatment, supported through the Grupo Fleury diagnostic partnership.
- Quimioterapia e Radioterapia Chemotherapy, immunotherapy, targeted therapy, and radiotherapy treatments focused on minimizing side effects and optimizing clinical results.
- Equipe Multidisciplinar Specialized multidisciplinary team providing physical and emotional support, including psychology, nutrition, physiotherapy, nursing, clinical pharmacy, occupational therapy, and stomatology services throughout oncology treatment.
- Cirurgias Oncológicas Oncology surgeries performed by specialists, with focus on efficient results and multidisciplinary support for better recovery.
- Biopsies and Diagnostic Procedures Safe and effective biopsies and diagnostic procedures to identify and monitor cancer progression with speed and precision.
- Infusion Therapy Area Comfortable and private spaces for chemotherapy infusion and related treatments, ensuring patient comfort and well-being.
- Wellness Space (Espaço de Bem-Estar) Integrative therapies, support groups, and workshops aimed at promoting physical, emotional, and mental balance throughout treatment.
- Patient Portal (odycare.app) Digital platform enabling patients to access appointments, exam results, and communicate with the care team.
Quantifiable outcome
- Reduced time to treatment initiation through optimized scheduling and coordination between outpatient, diagnostic, and hospital services
- +1 more outcomes
Companies that use Croma Oncologia
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles2 records
Croma Oncologia technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature4 records
Croma Oncologia partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- BP – A Beneficência Portuguesa de São PaulocoreBP – A Beneficência Portuguesa de São Paulo is a founding joint venture partner of Croma Oncologia, providing hospital infrastructure, oncology expertise, and access to one of Brazil's largest and most respected hospital networks. The partnership enables integration between Croma's outpatient clinics and BP's hospital services, supporting the coordinated care model.
- Atlântica Hospitais e Participações (Grupo Bradesco Seguros)coreAtlântica Hospitais e Participações, part of the Grupo Bradesco Seguros conglomerate, is a founding joint venture partner of Croma Oncologia. This partnership provides capital backing, hospital infrastructure access, and a direct connection to the Bradesco Saúde insurance ecosystem.
- Grupo FleurycoreGrupo Fleury, a leading Brazilian diagnostic medicine company, is a founding joint venture partner of Croma Oncologia. The partnership provides access to diagnostic laboratory services, imaging, and integrated testing capabilities that support the coordinated oncology care model.
- Felipe MattosocoreFelipe Mattoso is named as a founding partner in the Croma Oncologia joint venture. Referenced in the institutional page alongside BP, Atlântica Hospitais, and Grupo Fleury as part of the integrated care network.
- Labs A+coreLabs A+ is named as a founding partner in the Croma Oncologia joint venture. Referenced in the institutional page alongside BP, Atlântica Hospitais, and Grupo Fleury as part of the integrated diagnostic care network.
Scale indicators2 records
Recent moves8 records
Expansion highlights5 records
Croma Oncologia competitors and assessment
Company assessmentOthers
- Grupo Fleury: Leading Brazilian diagnostic medicine company and Croma's JV partner; provides laboratory and imaging services and is increasingly expanding into oncology-adjacent integrated care — comparable as both a partner and ecosystem participant.
- BP – A Beneficência Portuguesa de São Paulo: One of Brazil's largest hospital networks and Croma's founding JV partner; provides hospital infrastructure and oncology services to Croma's patients — comparable as both a strategic partner and parallel oncology care provider.
Direct peers
- Oncoclínicas: Brazil's largest dedicated outpatient oncology provider network with multi-city presence, offering chemotherapy, radiotherapy, and multidisciplinary cancer care under a coordinated model — directly comparable to Croma's Navegação Oncológica 360° positioning.
- A.C. Camargo Cancer Center: One of Brazil's most prestigious specialty oncology hospitals providing comprehensive cancer diagnosis, treatment, and research across solid tumors and hematological malignancies — competes with Croma for high-acuity oncology patients in São Paulo.
- Hospital de Amor: Formerly Hospital de Câncer de Barretos, a major Brazilian oncology specialty hospital network providing comprehensive cancer care across multiple units nationwide — directly comparable as a specialty oncology provider at significant scale.
Broad incumbents
- DASA (Diagnósticos da América): Brazil's largest diagnostic medicine company expanding into integrated oncology services through hospital partnerships; comparable to Croma in diagnostic capabilities and increasingly in oncology care delivery.
- Hospital Israelita Albert Einstein: Top-tier Brazilian hospital network offering comprehensive oncology services including chemotherapy, immunotherapy, and clinical trials; competes with Croma for high-acuity and executive-health oncology patients.
- Americas Medical City: Premium Rio de Janeiro-based hospital complex with significant oncology capabilities; competes with Croma's Botafogo unit for insured and private-pay oncology patients in the Rio de Janeiro market.
- Rede D'Or São Luiz: Brazil's largest private hospital network with significant oncology service lines across multiple states; competes broadly with Croma for insured oncology volume in São Paulo and Rio de Janeiro.
- Hospital Sírio-Libanês: Premier Brazilian general hospital with a strong oncology center and multidisciplinary care programs; competes with Croma for premium insured and private-pay oncology patients in São Paulo.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Croma Oncologia social profiles
Digital presenceCroma Oncologia compliance and trust
Trust signalCompliance1 record
Croma Oncologia financial estimates
Financial estimateRevenue estimate
Valuation estimate
Croma Oncologia leadership team
Management profileNumber of profiles
Profiles5 records
Croma Oncologia funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Croma Oncologia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Croma Oncologia
What does Croma Oncologia do?
Croma Oncologia operates a coordinated oncology care platform that integrates outpatient clinics, diagnostic services, and hospital facilities under its Navegação Oncológica 360° model. The company provides comprehensive cancer treatment — including consultations, chemotherapy, immunotherapy, targeted therapy, radiotherapy, surgeries, biopsies, hematology/onco-hematology, and multidisciplinary support — delivered across four physical units in São Paulo and Rio de Janeiro. Services are funded through Brazilian health insurance operators, private out-of-pocket payment, and value-based care contracts with operators and corporate clients.
Is Croma Oncologia a public or private company?
Croma Oncologia is a private company. It is classified as corporate owned and is currently operating.
When was Croma Oncologia founded?
Croma Oncologia was founded in -1. It employs 51 to 100 people.
Where is Croma Oncologia based?
Croma Oncologia is headquartered in São Paulo, Brazil, in the Latin America region.
How does Croma Oncologia make money?
Three revenue lines are on record. Health Insurance (Convênio) is the primary driver. The others are private/Particular Payment and value-Based Care Contracts with Operators.
Who are Croma Oncologia's main competitors?
Others on record are Grupo Fleury and BP – A Beneficência Portuguesa de São Paulo. Direct peers are Oncoclínicas, A.C. Camargo Cancer Center and Hospital de Amor. Broad incumbents are DASA (Diagnósticos da América), Hospital Israelita Albert Einstein, Americas Medical City, Rede D'Or São Luiz and Hospital Sírio-Libanês.
Does Croma Oncologia have an API?
No public API is recorded for Croma Oncologia.
What industry is Croma Oncologia in?
Croma Oncologia's product category is Oncology Care Services. Its primary akta.pro industry code is HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation), with a secondary code of HLAFAHAC, Oncology & Cancer Specialty Hospitals. Its NAICS code is 62111 and its SIC code is 8011.